Phylogica announced the appointment of Mr. Alan Tribe as the Chairperson of the company's Board of Directors alongside the appointment of Rohan Hockings as the company's Chief Executive Officer. Stephanie Unwin will resign from the position of Non-Executive Director and CEO following the company's next scheduled Board meeting on 27 April 2018 in order to give effect to the changes. Mr. Tribe brings substantial commercial experience to the Board and a deep interest in Phylogica's delivery platform developed through his time as a major shareholder in the company.

Mr. Tribe has increased his shareholding in the company to 19.9% to accompany his appointment as Chairperson. Dr. Hockings worked in both medicine and law including in the equity capital markets division of Freehills. Dr. Hockings has also spent 4 years working with McKinsey & Company on corporate strategy across a range of industries with a particular focus on healthcare.

He brings continuity of knowledge of Phylogica through his involvement in the strategic review as well as a background that allows him to bridge the technical and commercial elements of the company's future. The terms of Mr. Hockings engagement will be announced when formalised.